InvestorsHub Logo

thefamilyman

12/31/20 9:26 AM

#338368 RE: crashco #338343

That’s a true statement. It just does not apply here. Regardless of what happens with this Covid trial, IPIX still has other indications to pursue and the funding to do it with.

Crashco said,

Many a good man has died with live rounds in the chamber.


Thefamilyman said,

I agree with all of this but the last sentence. Covid is our best shot at significant gains in the short term. But it is still only one bullet in the IPIX magazine. We still have multiple shots at success.


Crashco said,

I am long and strong in IPIX. I am an investor not a trader. I believe Brilacidin has value for IBD, antibiotics and OM among other maladies. Kevetrin waits in the wings and if even marginally potent has huge value. But if B fails now, on this stage, IPIX will have suffered a fatal blow.